Zobrazeno 1 - 10
of 319
pro vyhledávání: '"Derek, Raghavan"'
Autor:
Zainab Shahid, Alicia L. Patrick, Michelle L. Wallander, Erin E. Donahue, Sally J. Trufan, Antoinette R. Tan, Jimmy J. Hwang, Earle F. Burgess, Brittany Ragon, Nilanjan Ghosh, Michael R. Grunwald, Peter M. Voorhees, Edward A. Copelan, Derek Raghavan
Publikováno v:
Vaccine: X, Vol 14, Iss , Pp 100289- (2023)
Purpose: Cancer patients are at high risk of developing severe illness from SARS-CoV-2 infection, but risk is lowered with receipt of COVID-19 vaccine. COVID-19 vaccination uptake among previously infected cancer patients may be influenced by an assu
Externí odkaz:
https://doaj.org/article/b5e30d5ae392467681a5ca38f490956d
Autor:
Roshan S. Prabhu, Reshika Dhakal, Amy S. Hicks, James McBride, Alicia L. Patrick, Christopher D. Corso, Tomain Murphy, Melissa Thonen, Edward H. Lipford, Derek Raghavan, Stuart H. Burri
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus is a current pandemic. We initiated a program of systematic SARS-CoV-2 polymerase chain reaction (PCR) testing in all asymptomatic patients receiving radiotherapy
Externí odkaz:
https://doaj.org/article/0ed5eb404c0441a88e3b1224cd1d49dd
Autor:
Jason Zhu, Chad Livasy, Erin E. Donahue, James T. Symanowski, Claud M. Grigg, Landon C. Brown, Justin T. Matulay, James T. Kearns, Derek Raghavan, Earle F. Burgess, Peter E. Clark
Publikováno v:
Translational Andrology and Urology. 12:228-240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e8c09e835ebc0295cb6909b44431e0f
https://doi.org/10.21037/tau-22-494
https://doi.org/10.21037/tau-22-494
Publikováno v:
Holland‐Frei Cancer Medicine. :1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ae50aeb49afb8305a38923182a41614
https://doi.org/10.1002/9781119000822.hfcm098.pub2
https://doi.org/10.1002/9781119000822.hfcm098.pub2
Publikováno v:
Holland‐Frei Cancer Medicine. :1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cfdaad7af69836807e3412012920d71
https://doi.org/10.1002/9781119000822.hfcm097.pub2
https://doi.org/10.1002/9781119000822.hfcm097.pub2
Autor:
Derek Raghavan
Publikováno v:
JCO Oncology Practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42b0a463d42faf25481d2bf4e29f948c
https://doi.org/10.1200/op.23.00138
https://doi.org/10.1200/op.23.00138
Autor:
Heinz-Josef Lenz, Philip A. Philip, John L. Marshall, Anthony F. Shields, Jimmy J. Hwang, Benjamin A. Weinberg, W. Michael Korn, Joanne Xiu, Richard M. Goldberg, Derek Raghavan, Axel Grothey, Alberto Puccini, Mohamed E. Salem
The efficacy of immunotherapy varies widely among different gastrointestinal cancers. Response to immune checkpoint inhibitors is shown to correlate with tumor mutation load (TML), mismatch repair deficiency (dMMR) status, and programmed cell death-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c723adac804b93f4a3786d9f817e3564
https://doi.org/10.1158/1541-7786.c.6541333
https://doi.org/10.1158/1541-7786.c.6541333
Autor:
Heinz-Josef Lenz, Philip A. Philip, John L. Marshall, Anthony F. Shields, Jimmy J. Hwang, Benjamin A. Weinberg, W. Michael Korn, Joanne Xiu, Richard M. Goldberg, Derek Raghavan, Axel Grothey, Alberto Puccini, Mohamed E. Salem
Comparison between percentages of PD-L1 positive tumors using the cut-off at >5% (as in our analysis) and the cut-off >1% (as FDA-approved test for pembrolizumab use in advanced gastric and gastroesophageal junction adenocarcinomas).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a311e25c5de0433826e3bd5bc11c30
https://doi.org/10.1158/1541-7786.22516273
https://doi.org/10.1158/1541-7786.22516273
Autor:
Brittany Knick Ragon, Danielle Boselli, Rupali Bose, Stephanie Begley, Melissa Aguiar, Kris Blackley, Nilay A. Shah, Aleksander L. Chojecki, Srinivasa Reddy R. Sanikommu, Jing Ai, Lawrence J Druhan, Nury M Steuerwald, Jai N Patel, James T. Symanowski, Belinda R. Avalos, Edward A. Copelan, Derek Raghavan, Thomas G. Knight, Michael R. Grunwald
Publikováno v:
Blood. 140:10993-10995
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c54ec969f6f5779ed47a647d708b17f
https://doi.org/10.1182/blood-2022-159179
https://doi.org/10.1182/blood-2022-159179
Autor:
Lisa M. Pye, Rupali Bose, Ryan Jacobs, Derek Raghavan, James T. Symanowski, Danielle Boselli, Nilanjan Ghosh, Edward A. Copelan, Kris Blackley, Bei Hu, Amy Soni, Steven I. Park, Belinda R. Avalos, Tommy Chen, Tamara K. Moyo
Publikováno v:
Cancer. 127:3991-3997
Background Aggressive large B-cell lymphomas (LBCLs) are curable, but previous studies have shown inferior outcomes in minorities. Nurse navigation programs can improve patient outcomes by providing patient support. This study presents the outcomes o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f854b65bd15179c6c5b578f93d4f8d
https://doi.org/10.1002/cncr.33779
https://doi.org/10.1002/cncr.33779